Capacity disruption, personalized medicines, and pharma investments in 2022

03/09/22 • 22 min

In episode 1 of the World Courier insights podcast, we speak to Jens Mattuschka, World Courier's regional vice president of the Nordics, Central, and Eastern Europe. Jens provides his unique perspectives on capacity disruption due to Omicron, the future of personalized medicines, the importance of control towers, and pharma sector investments in 2022.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Previous Episode

World Courier insights podcast - Trailer

Science is only impactful if it gets to the right people, in the right ways, at the right time.

Join us on the World Courier Insights podcast where we'll explore how innovation is moving pharma logistics forwards and why patient outcomes are so integral to everything we do at World Courier.

In each episode, we'll unpack what's going on in the news, focusing on the issues and challenges facing the sector. World Courier insiders are joined by industry experts, and we'll be taking a deep dive into the future of healthcare. So, make sure you subscribe at worldcourier.com/podcast or on your podcast app.

Hosted on Acast. See acast.com/privacy for more information.

Next Episode

Emerging cell and gene therapies, complex logistics eco-systems, and the need for greater industry collaboration

In this episode, we speak to Andreas Olpeter, Vice President of Sales & Business Development Healthcare at Arvato Supply Chain Solutions, and Andrea Zobel, Senior Director of Personalized Supply Chain at World Courier.

We discuss the emerging wave of new C&GT therapies and whether they are a niche, only available to small numbers of people, or if there is greater potential for wider patient access in the future. What are the complex ecosystems required for logistics success, and how will greater industry collaboration get more of these life-saving therapies to patients?

Hosted on Acast. See acast.com/privacy for more information.